Transient Leukemia Followed by Megakaryoblastic Leukemia in a Child with Mosaic Down Syndrome

References

• Ross J. D., Moloney W. C., Desforges J. F. Ineffective regulation of granulopoiesis masquerading as congenital leukemia in a Mongoloid child. J. Pediatr. 1963; 63: 1–10
   PubMed Web of Science ®Google Scholar
• Honda F., Punnett H. H., Charney E., Miller G., Thiede H. A. Serial cytogenetic and hematologic studies on a mongol with trisomy-21 and acute congenital leukemia. J. Pediatr. 1964; 65: 880–887
   PubMed Web of Science ®Google Scholar
• Engel R. R., Hammond D., Eitzman D. V., Pearson H., Krivit W. Transient congenital leukemia in 7 infants with mongolism. J. Pediatr. 1964; 65: 303–305
   PubMed Web of Science ®Google Scholar
• Wegelius R., Väänänen I., Koskella S.-I. Down's syndrome and transient leukemia-like disease in a newborn. Acta. Pediatr. Scand. 1967; 56: 301–306
   PubMed Web of Science ®Google Scholar
• Nagao T., Lampkin B. C., Hug G. A neonate with Down's syndrome and transient abnormal hematopoiesis: serial blood and bone marrow studies. Blond 1970; 36: 443–447
   PubMed Web of Science ®Google Scholar
• Clark A. C., Creegan W. J., Stass S. A., Thomas W. J., Schumacher H. R. Pseudoleukemia. Ineffective regulation of granulopoiesis. Arch. Pathol. Lab. Med. 1981; 105: 122–125
   PubMed Web of Science ®Google Scholar
• Zipursky A., Peeters M., Poon A. Megakaryoblastic leukemia and Down's syndrome: a review. Pediatr. Hematol. Oncol. 1987; 4: 211–230
   PubMed Web of Science ®Google Scholar
• Suda J., Eguchi M., Ozawa T., et al. Platelet peroxidase-positive blast cells in transient myeloproliferative disorder with Down's syndrome. Brit. J. Haematol. 1988; 68: 181–187
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Eguchi M., Sugita K., et al. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Blood 1988; 72: 15–23
   PubMed Web of Science ®Google Scholar
• Sartori P. C. E., Darbyshire P. J. Transient myeloproliferative disorder in Down's syndrome: three cases with megakaryocyte markers. Pediatr. Hematol. Oncol. 1991; 8: 139–145
   PubMed Web of Science ®Google Scholar
• Zipursky A., Poon A., Doyle J. Leukemia in Down syndrome: a review. Pediatr. Hematol. Oncol. 1992; 9: 139–149
   PubMed Web of Science ®Google Scholar
• Ridgeway D., Benda G. I., Magenis E., et al. Transient myeloproliferative disorder of the Down type in the normal newborn. Am. J. Dis. Child 1990; 144: 1117–1119
   PubMedGoogle Scholar
• Lin H.-P., Menaka H., Lim K.-H., Yong H.-S. Congenital leukemoid reaction followed by fatal leukemia. A case with Down's syndrome. Am. J. Dis. Child 1980; 134: 939–941
   PubMedGoogle Scholar
• Chu J.-Y., Weldon B. C. Acute leukemia in a patient with Down's syndrome and transient congenital leukemia. Am. J. Dis. Child. 1982; 136: 367
   PubMedGoogle Scholar
• Yokoyama S., Nito T., Irimada K., Yoshimura Y., Hayashi T. Acute megakaryoblastic leukemia preceded by refractory anemia with an excess of blast cells: leukemic transformation in an infant of Down syndrome recovering from transient abnormal myelopoiesis. Acta. Haematol. Jpn. 1984; 47: 62–70
   PubMedGoogle Scholar
• Morgan R., Hecht F., Cleary M. L., Sklar J., Link M. P. Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome. Blood 1985; 66: 1466–1468
   PubMed Web of Science ®Google Scholar
• Wong K. Y., Jones M. M., Srivasta A. K., Gruppo R. A. Transient myeloproliferative disorder and acute nonlymphoblastic leukemia in Down syndrome. J. Pediatr. 1988; 112: 18–22
   PubMed Web of Science ®Google Scholar
• Barnett P. L. J., Clark A. C. L., Garson O. M. Acute nonlymphocytic leukemia after transient myeloproliferative disorder in a patient with Down syndrome. Med. Pediatr. Oncol. 1990; 18: 347–353
   PubMedGoogle Scholar
• Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., McDonald S., Pulford K., Stein H., Mason D. Y. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP Complexes). J. Histochemistry and Cytochemistry 1984; 32: 219–229
   PubMed Web of Science ®Google Scholar
• deHarven E., Soligo D., Christensen H. Double labelling of cell surface antigens with colloidal gold markers. Histochem. J. 1990; 22: 18–23
   PubMedGoogle Scholar
• Dubé I. D., Greenberg M. L. Phenotypic heterogeneity in three cases of lymphoid malignancy with chromosomal translocations in 14q 11–13. Cytogenet. Cell Genet. 1986; 41: 215
   PubMedGoogle Scholar
• Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 1975; 98: 503–517
   PubMed Web of Science ®Google Scholar
• Saiki R. K., Scharf S., Faloona F., Mullis K., Horn G., Erlich H. A., Arnheim N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350–1354
   PubMed Web of Science ®Google Scholar
• Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487–491
   PubMed Web of Science ®Google Scholar
• Woods W. G., Ruymann F. B., Lampkin B. C., Buckley J. D., Bernstein I. D., Srivasta A. K., Smithson W. A., Benjamin D. R., Feif S. A., Kim T. H., Odom L. F., Wells R. J., Hammond G. D. The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia. Cancer 1990; 66: 1106–1113
   PubMed Web of Science ®Google Scholar
• Brodeur G. M., Dahl G. V., Williams D. L., Tipton R. E., Kalwinsky D. K. Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn. Blood 1980; 55: 691–693
   PubMed Web of Science ®Google Scholar
• Heaton D. C., Fitzgerald P. H., Fraser G. J., Abbott G. D. Transient leukemoid proliferation of the cytogenetically unbalanced +21 cell line of a constitutional mosaic boy. Blood 1981; 57: 883–887
   PubMed Web of Science ®Google Scholar
• Weinberg A. G., Schiller G., Windmiller J. Neonatal leukemoid reaction. An isolated manifestation of mosaic trisomy 21. Am. J. Dis. Child. 1982; 136: 310–311
   PubMedGoogle Scholar
• Seibel N. L., Sommer A., Miser J. Transient neonatal leukemoid reactions in mosaic trisomy 21. J. Pediatr. 1984; 104: 251–254
   PubMed Web of Science ®Google Scholar
• Zipursky A., Thomer P., De Harven E., Christensen H., Doyle J. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome. Leukemia Research 1994; 18: 163–171
   PubMed Web of Science ®Google Scholar
• Slørdahl S. H., Smeland E. B., Holte H., Grønn M., Lie S. O., Seip M. Leukemic blasts with markers of four cell lineages in Down's syndrome (“megakaryoblastic leukemia”). Med. and Pediatr. Oncol. 1993; 21: 254–258
   PubMedGoogle Scholar
• Kojima S., Matsuyama T., Sato T., Horibe K., Konishi S., Tsuchida M., Hayashi Y., Kigasawa H., Akiyama Y., Okamura J., Nakahata T., Bessho F., Eguchi M., Nakazawa S., Ueda R. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood. 1990; 76: 2348–2353
   PubMed Web of Science ®Google Scholar
• Cuneo A., Michaux J.-L., Fen-Ant A., et al. Correlation of cytogenetic patterns and clinicobiological features in adult acute leukemia expressing lymphoid markers. Blood 1992; 79: 720–727
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Raimondi S. C., Head D. R., et al. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood. 1991; 78: 1327–1337
   PubMed Web of Science ®Google Scholar
• Smith F. O., Lampkin B. C., Versteeg C., et al. Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance. Blood 1992; 79: 2415–2422
   PubMed Web of Science ®Google Scholar
• Sandhaus L. M., Chen T. L., Ettinger L. J., Hirst-Allen A., Mehta K., Raskova J. Significance of increased proportion of CD 10-positive cells in nonmalignant bone marrows of children. Am. J. Pediatr. Hematol./Oncol. 1933; 15: 65–70
   Google Scholar
• Miyashita T., Asada M., Fujimoto J., et al. Clonal analysis of transient myeloproliferative disorder in Down's syndrome. Leukemia 1991; 5: 56–59
   PubMed Web of Science ®Google Scholar
• Kurahashi H., Hara J., Yumura-Yagi K., et al. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. Blood 1991; 77: 1161–1163
   PubMed Web of Science ®Google Scholar
• Lazarus K. H., Heerema N. A., Palmer C. G., Baehner R. L. The myeloproliferative reaction in a child with Down syndrome: cytological and chromosomal evidence for a transient leukemia. Am. J. of Hematol 1981; 11: 417–423
   PubMed Web of Science ®Google Scholar
• Ghosh K. Transient abnormal myelopoiesis in Down's syndrome—are some of them truly leukaemic?. Leukemia Research 1992; 6: 545–546
   Web of Science ®Google Scholar
• Zipursky A., Doyle J. Leukemia in newborn infants with Down syndrome (letter). Leukemia Research 1993; 17: 195
   PubMed Web of Science ®Google Scholar
• Schunk G. J., Lehman W. L. Mongolism and congenital leukemia. J. Amer. Med. Assoc 1954; 155: 250–251
   PubMed Web of Science ®Google Scholar
• Becroft D. M. O., Zwi L. J. Perinatal visceral fibrosis accompanying the megakaryoblastic leukemoid reaction of Down syndrome. Pediatr. Pathol. 1990; 10: 397–406
   PubMedGoogle Scholar
• Doyle J., Poon A., Zipursky A. Transient leukemia and Down Syndrome. Blood 1991; 78: 41a
   Google Scholar